Home
About
Glossary
Recommendation
Recommended In Favor
Conditional recommendation
Certainty of evidence
Low
WHO suggests paclitaxel or pegylated liposomal doxorubicin for pharmacological treatment for people living with HIV with Kaposi’s sarcoma.
Year
2025
Institution
World health organization
Guideline
Not available